Bio Protocol vs Lisk — how do they compare? Bio Protocol trades at Rp442.5 (market cap Rp1,01T, Rp168,09M 24h volume), while Lisk trades at Rp1,371 (market cap Rp308,72M, Rp90,93M 24h volume). The key difference: Bio Protocol is far larger — about 3271.6× Lisk's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 224,9M / 400M LSK (57%) for Lisk. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Lisk for 25 Days on average.
| BIO | LSK | |
|---|---|---|
Market Cap | Rp1,01T | Rp308,72M |
Volume (24h) | Rp168,09M | Rp90,93M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 224,9M / 400M LSK (57%) |
Typical Hold Time | 18 Days | 25 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Lisk (LSK) is a Layer 2 blockchain designed to boost Web3 adoption in emerging markets through Ethereum integration. It offers a developer-friendly SDK for building blockchain applications and supports scalable sidechains connected to its mainchain for efficient development.
Read more on LSK →